Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Virus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effect

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Virus isolation is a laboratory procedure used to detect and identify viral agents in clinical specimens. In this process, a suspected viral agent is introduced into a specially prepared solution, known as a tissue culture medium, which provides the necessary nutrients and environment for the virus to grow and multiply. The culture is then monitored over a period of time to observe any cytopathic effects, which are changes in the cells that indicate the presence of the virus. This method is crucial for diagnosing viral infections, as it allows for the direct observation of viral activity and helps in the presumptive identification of the virus based on the effects it has on the cultured cells.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The procedure of virus isolation through tissue culture is indicated for the following conditions:

  • Suspected Viral Infections This procedure is performed when there is a clinical suspicion of a viral infection based on patient symptoms and history.
  • Diagnostic Confirmation It is utilized to confirm the presence of a specific virus in a sample, aiding in the accurate diagnosis of viral diseases.
  • Monitoring Viral Load Virus isolation can be used to assess the viral load in a patient, which is important for treatment decisions and monitoring disease progression.

2. Procedure

The procedure for virus isolation involves several critical steps to ensure accurate results.

  • Step 1: Sample Collection A clinical specimen, such as blood, tissue, or other bodily fluids, is collected from the patient suspected of having a viral infection. This sample must be handled carefully to prevent contamination and preserve the viability of the virus.
  • Step 2: Inoculation of Tissue Culture The collected specimen is then inoculated into a tissue culture medium. This medium is specifically designed to support the growth of viruses and contains nutrients that facilitate viral propagation.
  • Step 3: Incubation The inoculated culture is placed in an incubator under controlled conditions, including temperature and humidity, to promote viral growth. This incubation period allows the virus to replicate within the cultured cells.
  • Step 4: Observation After a designated incubation period, the culture is observed for cytopathic effects, which are visible changes in the cells that indicate viral infection. These effects may include cell lysis, rounding, or detachment from the culture surface.
  • Step 5: Presumptive Identification Based on the observed cytopathic effects, laboratory personnel can make a presumptive identification of the virus present in the culture. Further testing may be conducted for definitive identification.

3. Post-Procedure

After the virus isolation procedure, the laboratory will typically document the findings and any cytopathic effects observed during the culture observation. The results are then communicated to the healthcare provider for further clinical decision-making. Depending on the findings, additional tests may be recommended to confirm the specific type of virus and to guide treatment options. It is also important to ensure that the laboratory follows appropriate biosafety protocols when handling viral cultures to prevent any risk of exposure to pathogenic viruses.

Short Descr VIRUS INOCULATION TISSUE
Medium Descr VIRUS TISS CUL INOCULATION CYTOPATHIC EFFECT
Long Descr Virus isolation; tissue culture inoculation, observation, and presumptive identification by cytopathic effect
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 2
CCS Clinical Classification 206 - Microscopic examination (bacterial smear, culture, toxicology)
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Q4 Service for ordering/referring physician qualifies as a service exemption
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
CR Catastrophe/disaster related
GW Service not related to the hospice patient's terminal condition
LT Left side (used to identify procedures performed on the left side of the body)
QW Clia waived test
RT Right side (used to identify procedures performed on the right side of the body)
Date
Action
Notes
2011-01-01 Changed Short description changed.
2001-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"